Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis
NCT02873949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-02-01
Summary
Etiopathology of periodontitis is complex and various risk factors are known :
* Bacterial factors: major risk factor. Although the presence of periodontopathogen bacteria is necessary for the onset of periodontitis, these microorganisms are not sufficient for progression of all periodontal disease.
* Immune factor: host immune response modulates the disease evolution to destruction or recovery. The most studied cytokine in periodontology is IL-1 that induces various immune reactions and bone resorption directly or indirectly through the stimulation of prostaglandin E2 (PGE2) release. PGE2 activates the matrix metalloproteinases that are responsible of the degradation of bone extracellular matrix.
Cytokine production, especially TNFα, IL-1β, IL-6 and IL-8, by some immune cells is modulated by new identified molecules such as Triggering Receptor Expressed on Myeloid cells (TREM) whose role in periodontitis is unknown.
The purpose of this study is to compare concentrations of soluble TREM-1 and TREM-2 markers in infected sites and in healthy sites in patients affected by periodontitis.
Other purposes are
1. Comparison of soluble TREM-1 and TREM-2 concentrations in healthy sites in patients affected by periodontitis and in healthy patients
2. Comparison of soluble TREM-1 and TREM-2 concentrations before and after etiologic periodontitis treatment
3. Estimation of the correlation between soluble TREM-1 and TREM-2 concentrations and clinical signs of periodontitis
4. Description of soluble TREM-1/TREM-2 ratio before and after etiologic treatment
5. Description of presence of some bacteria in sites analyzed for soluble TREM-1 and TREM-2
6. Search for the most observed bacteria in presence of high concentrations of soluble TREM-1 and TREM-2 before and after etiologic treatment
7. Evaluation of the impact of psychological stress measured through salivary cortisol level in saliva on TREM-1 and -2 expression
8. Evaluation of the impact of psychological stress through stress and anxiety auto-questionnaires (Spielberger and Cohen) on soluble TREM-1 and TREM-2 concentrations in crevicular fluid of healthy and pathologic teeth.
Conditions
- Periodontitis
Interventions
- BIOLOGICAL
-
Crevicular samples (1-10µl)
In periodontitis patients: from 2 sites affected by periodontitis and 1 healthy site, 2 samples/site, before and after treatment In non-periodontitis individuals: 2 samples from 1 site
- BIOLOGICAL
-
Saliva samples (1ml)
- OTHER
-
Etiologic treatment
education on oral hygiene, scaling and root planing
- OTHER
-
Psychometric tests
Spielberger State-Trait Anxiety Inventory and Cohen Perceived Stress Scale
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Catherine BISSON · Service Odontologie - Site Heydenreich - CHRU Nancy
-
Sébastien GIBOT · Service Réanimation Médicale - Hôpital Central - CHRU Nancy
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- France
Study Locations
More Related Trials
-
Effects of Antibiotic Therapy on the Short and Long-term Results of Periodontitis Treatments
NCT05065034 ·Status: UNKNOWN
-
Efficacy of Proanthocyanidins in Non-Surgical Periodontal Therapy
NCT05015387 ·Status: COMPLETED ·Phase: PHASE2
-
Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients
NCT00399620 ·Status: UNKNOWN ·Phase: NA
-
Interaction Between Immune Cells and Bacteria Associated With Periodontitis
NCT03225950 ·Status: COMPLETED
-
Immunoregulation of Periodontal Diseases
NCT02567019 ·Status: UNKNOWN ·Phase: NA
-
Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
NCT01568697 ·Status: RECRUITING
-
Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Periodontal Disease
NCT02848378 ·Status: COMPLETED
-
The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.
NCT07027137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Gut Microbial Changes After Periodontal Treatment
NCT04982302 ·Status: COMPLETED
-
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
NCT06291350 ·Status: RECRUITING
-
Effect of Periodontal Therapy in the Systemic Status of Individuals With Chronic Periodontitis and Diabetes Type 2
NCT02589314 ·Status: TERMINATED
-
Diagnosis of Periodontal Disease Using Genetic Marker in Saliva
NCT02069574 ·Status: UNKNOWN ·Phase: NA
-
Study of the Periodontal Microbiota in Gingival Cicatricial Pemphigoid Patients. Bicentric Pilot Study.
NCT04555681 ·Status: COMPLETED
-
Serum TRAP-5b Levels in Patients With Generalized Chronic Periodontitis
NCT03043066 ·Status: COMPLETED ·Phase: NA
-
IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis
NCT02710903 ·Status: TERMINATED ·Phase: NA
-
Multi-omics Analysis of Oral-gut Microbial Profiles
NCT06261515 ·Status: RECRUITING ·Phase: NA
-
A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan
NCT00199290 ·Status: COMPLETED ·Phase: PHASE2
-
The Immune Response After Periodontal Treatment
NCT03501316 ·Status: COMPLETED ·Phase: NA
-
Mechanism of Indocyanine Green-based Photodynamic Therapy for Treating Periodontitis
NCT03557827 ·Status: UNKNOWN ·Phase: PHASE3
-
Collection of Gingival Crevicular Fluid From Periodontitis Patients
NCT00763048 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
NCT06505759 ·Status: RECRUITING ·Phase: PHASE1
-
Periodontitis and Inflammation: Study on Biological Samples
NCT06012019 ·Status: RECRUITING
-
Evaluation of Metronidazole Hydrogel 25% in Stage II and III Periodontitis
NCT04983849 ·Status: COMPLETED ·Phase: PHASE4
-
Periodontal Disease and Circulatory Microbial Components
NCT01154855 ·Status: COMPLETED
-
Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy
NCT02879903 ·Status: UNKNOWN ·Phase: EARLY_PHASE1